A practical strategy for the routine use of BIOMED‐2 PCR assays for detection of B‐ and T‐cell clonality in diagnostic haematopathology
- 6 June 2007
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 138 (1), 31-43
- https://doi.org/10.1111/j.1365-2141.2007.06618.x
Abstract
BIOMED-2 polymerase chain reaction (PCR) assays for clonality analysis of immunoglobulin (IG) and T-cell receptor (TCR) gene rearrangements were evaluated in routine haematopathological practice where paraffin-embedded tissues constitute the majority of specimens. One hundred and twenty-five fresh/frozen and 316 paraffin specimens were analysed for DNA quality and clonality. Seventy-nine per cent of paraffin specimens yielded PCR products of over 300 bp. These specimens and all fresh/frozen specimens were analysed with the complete set of BIOMED-2 reactions for IG (8 reactions) and/or TCR (6 reactions) gene rearrangements. The rate of detection of clonality was 96% in mature B-cell neoplasms and 98% in mature T-cell neoplasms and there were no significant differences in these rates between paraffin and fresh/frozen specimens. As the value of sole use of any individual BIOMED-2 reaction in clonality detection was limited, we assessed combinations of reactions that gave the greatest sensitivity with fewest reactions and were applicable for both fresh/frozen and paraffin specimens. For IG gene rearrangements, three reactions combining one targeting the IG heavy chain framework-2 region and two targeting the IG kappa locus achieved a 91% detection rate. For TCR gene rearrangements, the two TCR gamma reactions gave a 94% detection rate. We therefore recommend this strategy as the first-line assays for routine B- and T-cell clonality analysis in diagnostic haematopathology.Keywords
This publication has 33 references indexed in Scilit:
- Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936Leukemia, 2006
- Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin’s lymphomas with high rates of somatic hypermutationJournal of Clinical Pathology, 2006
- Evaluation of B-cell clonality in archival skin biopsy samples of cutaneous B-cell lymphoma by immunoglobulin heavy chain gene polymerase chain reactionLeukemia & Lymphoma, 2006
- Application of BIOMED-2 Primers in Fixed and Decalcified Bone Marrow BiopsiesThe Journal of Molecular Diagnostics, 2005
- BIOMED-2 Multiplex Immunoglobulin/T-Cell Receptor Polymerase Chain Reaction Protocols Can Reliably Replace Southern Blot Analysis in Routine Clonality DiagnosticsThe Journal of Molecular Diagnostics, 2005
- Routine Analysis of IgVHMutational Status in CLL Patients using BIOMED-2 Standardized Primers and ProtocolsLeukemia & Lymphoma, 2004
- Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignanciesLeukemia, 2004
- T cell lymphoproliferative disorder following bone marrow transplantation for severe aplastic anemiaBone Marrow Transplantation, 2000
- PCR amplification from paraffin-embedded tissues: recommendations on fixatives for long-term storage and prospective studies.Genome Research, 1991
- Immunoglobulin-Gene Rearrangements as Unique Clonal Markers in Human Lymphoid NeoplasmsNew England Journal of Medicine, 1983